Grants and Contributions:
Title:
Covid-19 Project EXHALE
Agreement Number:
952647
Agreement Value:
$500,000.00
Agreement Date:
Jun 15, 2020 - Oct 1, 2021
Description:
To accelerate the screening and validation of therapeutic drugs to treat COVID-19, Project Exhale will develop two critical new media products and associated protocols to culture human alveolar cells in 2D and 3D.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Vancouver, British Columbia, CA V6A 1B6
Reference Number:
172-2020-2021-Q2-952647
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
135714426
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The total amended value is 33,000 dollars.
Amendment Date
Sep 27, 2021
Recipient's Legal Name:
StemCell Technologies Canada Inc.
Federal Riding Name:
Vancouver East
Federal Riding Number:
59035
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710
Amendments: